GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 789 filers reported holding GLAXOSMITHKLINE PLC in Q3 2018. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $823,000 | +201.5% | 18,900 | +204.8% | 0.01% | +400.0% |
| Q4 2021 | $273,000 | +27.6% | 6,200 | +9.1% | 0.00% | -50.0% |
| Q3 2020 | $214,000 | -99.1% | 5,683 | -98.9% | 0.00% | -99.1% |
| Q4 2019 | $23,419,000 | +19.9% | 498,389 | +8.9% | 0.43% | -20.8% |
| Q3 2019 | $19,538,000 | +6.9% | 457,787 | +0.3% | 0.54% | +4.7% |
| Q2 2019 | $18,275,000 | +8686.1% | 456,636 | +8264.8% | 0.51% | +6325.0% |
| Q1 2019 | $208,000 | -1.4% | 5,459 | +4.3% | 0.01% | -38.5% |
| Q2 2018 | $211,000 | -65.0% | 5,233 | -69.2% | 0.01% | -76.8% |
| Q4 2017 | $603,000 | -53.6% | 16,996 | -43.6% | 0.06% | -55.6% |
| Q2 2017 | $1,300,000 | +543.6% | 30,141 | +520.1% | 0.13% | +260.0% |
| Q2 2015 | $202,000 | -21.4% | 4,861 | -12.9% | 0.04% | -2.8% |
| Q3 2014 | $257,000 | -5.2% | 5,580 | +3.3% | 0.04% | -12.2% |
| Q3 2013 | $271,000 | +11.1% | 5,404 | +10.8% | 0.04% | -8.9% |
| Q2 2013 | $244,000 | – | 4,879 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |